课题基金 / 基金详情

Mechanisms of myocardial ischemia and reperfusion

Mechanisms of myocardial ischemia and reperfusion
心肌缺血和再灌注的机制
批准号:
8774406
负责人:
Dorothy Eileen Vatner
金额:
$7.95万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-12-01 至 2015-11-30

项目摘要

项目成果

Dorothy Eileen Vatner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The most common form of heart disease is myocardial ischemia, which is characterized by an insufficient supply of blood, substrates and oxygen to the heart due to coronary artery obstruction. If not treated, irreversible damage ensues in the form of myocardial infarction (heart attack). The overall aim of this Program Project application is to identify mechanisms which are fundamental to the understanding of ischemic heart disease, which will be accomplished by utilizing a combined approach by integrative and basic scientists. There are 4 projects and 5 cores, with major interactions among projects and cores. All the projects include cellular and molecular studies as well as integrative whole animal physiology. All Projects use all the Cores, which is the glue that binds the Projects and provides the synergy characteristic of a Program Project. One unique aspect of this Program Project is the use of the large mammalian model, which is central to Projects 1 and 2. Project 1, "Effects of Cardiac Denervation on Ischemic Protection", involves the study of the mechanisms of cardiac protection in the second window of ischemic protection in chronically instrumented conscious swine. The project is based, in part, on the novel observation that either regional cardiac denervation or adrenergic receptor blockade abrogates the second window of protection. Project 2, "Molecular Mechanisms in Chronically Stunned Myocardium", parallels Project 1 in that it also uses the conscious, chronically instrumented swine model, but focuses on the chronic, repetitive stunning model developed in this project in the last funding period. This model recapitulates many of the features of hibernating myocardium in patients with chronic coronary artery disease, and also exhibits myocardial protection, potentially through a third window of protection. Project 3, "Cell Death Promoting Mechanisms of Mst 1", also involves the study of cell survival and cell death with special emphasis on the molecule Mst 1, mammalian sterile kinase. This project is based on findings during the current funding period that Mst 1, belonging to a recently identified evolutionary conserved protein kinase cascade activated by myocardial ischemia, has unexpected and diverse functions not limited to pro-apoptosis but which contributes to cardiac dysfunction. Project 4, "Survival Role of H11 Kinase during Myocardial Ischemia", is a new project which focuses on cardioprotection mechanisms invoked by H11 kinase. This project is based on work completed during the initial funding period, where one of the novel molecular mechanisms involved in myocardial stunning and hibernation discovered was H11 kinase, a molecule not previously studied in the heart, and found to afford powerful protection against myocardial ischemia. The Program Project approach is exemplified by the interactions among Projects and Cores, which strengthens each individual project and is designed to improve our understanding and delineate new therapies for patients with coronary artery disease.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/s0076-6879(08)04016-0
发表时间: 2009
期刊: METHODS IN ENZYMOLOGY
影响因子: --
作者: [Perry, Cynthia N., Kyoi, Shiori, Hariharan, Nirmala, Takagi, Hiromitsu, Sadoshima, Junichi, Gottlieb, Roberta A.]
通讯作者: Gottlieb, Roberta A.
DOI: 10.1161/hypertensionaha.114.04456
发表时间: 2015-02
期刊: Hypertension (Dallas, Tex. : 1979)
影响因子: --
作者: [Sehgel NL, Sun Z, Hong Z, Hunter WC, Hill MA, Vatner DE, Vatner SF, Meininger GA]
通讯作者: Meininger GA
Why So Few New Cardiovascular Drugs Translate to the Clinics.
为什么很少有新的心血管药物转化为临床。
DOI: 10.1161/circresaha.116.309512
发表时间: 2016
期刊: Circulation research
影响因子: 20.1
作者: [Vatner,StephenF]
通讯作者: Vatner,StephenF
DOI: 10.1161/circresaha.108.193102
发表时间: 2009-04-10
期刊: Circulation research
影响因子: 20.1
作者: [Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, Vatner DE, Vatner SF, Abdellatif M]
通讯作者: Abdellatif M
14
    Adenylyl Cyclase Type 5 Inhibition to Treat Myocardial Infarction
    • 批准号:
      9764847
    • 项目类别:
    • 资助金额:
      $67.34万
    • 财政年份:
      2018
    • 负责人:
      Dorothy Eileen Vatner
    • 依托单位:
    INHIBITION OF ADENYLYL CYCLASE TYPE 5: HEALTHFUL AGING PROTECTION
    • 批准号:
      9321949
    • 项目类别:
    • 资助金额:
      $19.88万
    • 财政年份:
      2016
    • 负责人:
      Dorothy Eileen Vatner
    • 依托单位:
    SFRP2, cell survival, and coronary vascular angiogenesis
    • 批准号:
      8875747
    • 项目类别:
    • 资助金额:
      $45.27万
    • 财政年份:
      2013
    • 负责人:
      Dorothy Eileen Vatner
    • 依托单位:
    SFRP2, cell survival, and coronary vascular angiogenesis
    • 批准号:
      8563199
    • 项目类别:
    • 资助金额:
      $45.23万
    • 财政年份:
      2013
    • 负责人:
      Dorothy Eileen Vatner
    • 依托单位:
    海外基金